Absence of Anterior Fontanelle in a Newborn (Closed / Non-Palpable Anterior Fontanelle)

Leave a reply

The anterior fontanelle is the largest fontanelle of the newborn skull and normally remains open during early infancy to allow brain growth and skull expansion.

1. Normal Anatomy and Physiology

The anterior fontanelle lies at the junction of:
- Two frontal bones
- Two parietal bones
Shape: Diamond-shaped
Average size at birth: 1–4 cm
Normal closure: 9–18 months

Functions:

Allows rapid brain growth
Facilitates molding during vaginal delivery
Serves as a clinical window for intracranial pressure assessment

When the Anterior Fontanelle Is Absent at Birth

A non-palpable or absent anterior fontanelle suggests premature fusion of cranial sutures or abnormal skull ossification.

This finding must always be evaluated carefully because it may indicate craniosynostosis or underlying pathology.

Causes of Absent Anterior Fontanelle

1. Craniosynostosis (Most Important Cause)

Premature fusion of one or more cranial sutures prevents normal skull expansion.

Types include:

Suture involved	Resulting head shape
Sagittal	Scaphocephaly (long narrow skull)
Coronal	Brachycephaly
Metopic	Trigonocephaly
Multiple sutures	Oxycephaly

Consequences:

Restricted skull growth
Raised intracranial pressure
Neurodevelopmental impairment if untreated

2. Hyperthyroidism (Congenital Thyrotoxicosis)

Seen in infants of mothers with Graves disease

Mechanism:

Increased thyroid hormone → accelerated bone maturation
Leads to early closure of sutures and fontanelles

Associated features:

Irritability
Tachycardia
Poor weight gain
Goiter
Exophthalmos (rare in neonates)

3. Microcephaly

Brain growth failure leads to small skull size, so sutures close early.

Common causes:

Intrauterine infections (TORCH)
Genetic syndromes
Severe hypoxic injury
Metabolic disorders

4. Skeletal Dysplasias

Some bone disorders cause abnormal skull ossification.

Examples:

Osteopetrosis
Thanatophoric dysplasia

5. Normal Variant

Rarely the fontanelle is very small or difficult to palpate, but sutures remain open and skull growth is normal.

Clinical Evaluation

1. History

Ask about:

Maternal history

Hyperthyroidism
Antithyroid drugs
TORCH infections

Perinatal history

Birth trauma
Neonatal illness

Family history

Craniosynostosis
Genetic syndromes

Developmental history

Feeding difficulty
Poor growth
Developmental delay

2. Physical Examination

Head Examination

Assess:

Feature	Significance
Head circumference	Detect microcephaly
Skull shape	Suggest specific craniosynostosis
Palpation of sutures	Check if fused or ridged
Remaining fontanelles	Posterior fontanelle status

Look for Associated Signs

Neurologic:

Irritability
Vomiting
Bulging veins

Systemic:

Signs of hyperthyroidism
Dysmorphic features

Investigations

1. Imaging

Skull X-ray

Shows fused sutures

Cranial ultrasound

If some fontanelle is open

CT scan with 3D reconstruction

Gold standard for diagnosing craniosynostosis

2. Laboratory Tests

If systemic cause suspected:

Test	Purpose
Thyroid function test	Detect neonatal thyrotoxicosis
TORCH screening	If infection suspected
Genetic testing	Syndromic craniosynostosis

Complications

If due to craniosynostosis:

Raised intracranial pressure
Visual impairment
Developmental delay
Cognitive impairment

Management

1. Craniosynostosis

Referral to pediatric neurosurgery

Treatment:

Surgical cranial vault remodeling
Usually performed within first year of life

2. Neonatal Hyperthyroidism

Treat underlying condition:

Antithyroid drugs
Beta-blockers

3. Microcephaly

Management depends on cause:

Developmental support
Treat underlying infection/metabolic disease

Clinical Pearls (High-Yield)

Anterior fontanelle absent at birth → think craniosynostosis first.
Always measure head circumference.
Check skull shape and sutures carefully.
3D CT scan confirms diagnosis.
Early surgical correction prevents intracranial hypertension and neurodevelopmental damage.

Creatine Kinase (CK) – High-Yield Medical Notes

Leave a reply

1. Definition

Creatine kinase (CK), also called creatine phosphokinase (CPK), is an intracellular enzyme that catalyzes the reversible conversion:Creatine+ATP↔Phosphocreatine+ADPCreatine + ATP \leftrightarrow Phosphocreatine + ADPCreatine+ATP↔Phosphocreatine+ADP

This reaction is crucial for energy storage and rapid regeneration of ATP, especially in muscle and brain tissues.

2. Location in Body

CK is present mainly in tissues with high energy demand:

Tissue	CK concentration
Skeletal muscle	Highest
Cardiac muscle	High
Brain	Moderate
Smooth muscle	Low

Because CK is intracellular, serum CK rises when cell membrane damage occurs.

3. CK Isoenzymes

CK exists in three isoenzymes, formed by combinations of M (muscle) and B (brain) subunits.

Isoenzyme	Structure	Major Source	Clinical significance
CK-MM	M + M	Skeletal muscle	Muscle injury, rhabdomyolysis
CK-MB	M + B	Cardiac muscle	Myocardial injury
CK-BB	B + B	Brain, smooth muscle	CNS injury

Distribution

CK-MM: ~95–100% of total CK in normal serum
CK-MB: <5% normally
CK-BB: normally absent in serum

4. Normal Values

Normal ranges vary by lab.

Typical reference:

Group	CK (U/L)
Adult male	50–200
Adult female	40–150
Children	Higher than adults
Neonates	Can be very high after birth

5. Causes of Elevated CK

A. Skeletal Muscle Disorders

Most common cause.

Examples:

Muscular dystrophy (e.g., Duchenne muscular dystrophy)
Inflammatory myopathies
- Polymyositis
- Dermatomyositis
Trauma
Intramuscular injections
Vigorous exercise

B. Rhabdomyolysis

Massive CK elevation.

Causes:

Crush injury
Drugs (statins)
Heat stroke
Severe infections

CK may rise >5000–10,000 U/L.

C. Cardiac Causes

CK-MB rises in myocardial injury.

Example:

Myocardial Infarction

However, CK-MB is now largely replaced by troponins.

D. Neurologic Disorders

CK-BB may increase in:

Stroke
Brain trauma
Seizures

Example:

Stroke

E. Other Causes

Hypothyroidism
Alcohol abuse
Surgery
Prolonged immobilization
Severe infections

6. CK in Myocardial Infarction

Historically important marker.

Parameter	CK-MB
Rise	3–6 hours
Peak	12–24 hours
Normalization	48–72 hours

Used previously to detect reinfarction.

Now replaced mainly by troponin I/T.

7. CK in Pediatric Practice

Important uses:

Screening for muscular dystrophy

Very high CK in:

Duchenne muscular dystrophy
Becker muscular dystrophy

Levels may be 10–100× normal.

Evaluation of Hypotonia

Used when evaluating:

floppy infant
muscle weakness

Evaluation of Rhabdomyolysis

Symptoms:

myalgia
weakness
dark urine (myoglobinuria)

8. Causes of Decreased CK

Rare clinical significance.

Seen in:

Low muscle mass
Chronic illness
Pregnancy

9. Drugs Causing Elevated CK

Important clinically.

Examples:

Drug	Mechanism
Statins	Myopathy
Antipsychotics	Neuroleptic malignant syndrome
Corticosteroids	Muscle breakdown

Example condition:
Neuroleptic Malignant Syndrome

10. Investigation Panel When CK is Elevated

Test	Purpose
CK-MB	Cardiac source
Troponin	MI confirmation
AST / ALT	Muscle vs liver
LDH	Tissue injury
Serum myoglobin	Rhabdomyolysis
Urine myoglobin	Kidney injury

11. CK in Rhabdomyolysis Severity

CK level	Interpretation
<1000	Mild
1000–5000	Moderate

5000 | Severe muscle injury |
15000 | High risk of renal failure |

12. Clinical Pearls (Exam High-Yield)

CK-MM → skeletal muscle injury
CK-MB → cardiac muscle
CK-BB → brain
Duchenne muscular dystrophy → CK extremely high
CK rises after muscle trauma/exercise
CK-MB replaced by troponin in MI diagnosis

✅ One-line exam memory tip

“CK rises with muscle damage — skeletal (MM), cardiac (MB), brain (BB).”

Complicated Vs Uncomplicated UTI (Notes) – Clinical Practice and Diagnosis

Leave a reply

1. Definition

Type	Definition
Uncomplicated UTI	Infection of the lower urinary tract (bladder and urethra) occurring in an otherwise healthy, non-pregnant woman with a structurally and functionally normal urinary tract.
Complicated UTI	UTI occurring in individuals with structural or functional abnormalities of the urinary tract, comorbidities, or other risk factors that increase risk of treatment failure or recurrence.

2. Typical Patients

Type	Common in
Uncomplicated	Healthy, premenopausal, non-pregnant females
Complicated	Males, pregnant females, children, elderly, diabetics, catheterized patients, immunocompromised patients

3. Etiology

Type	Common Pathogens	Special Pathogens
Uncomplicated	E. coli (≈80–90%), Staphylococcus saprophyticus	Rarely Klebsiella, Proteus
Complicated	E. coli, Klebsiella, Proteus, Enterobacter, Pseudomonas, Enterococcus, Candida	Often multidrug-resistant (MDR) organisms

4. Predisposing / Risk Factors

Uncomplicated:

Female gender (short urethra)
Sexual activity
Spermicides

Complicated:

Structural: Stones, strictures, obstruction (BPH, vesicoureteral reflux)
Functional: Neurogenic bladder, indwelling catheter
Systemic: Diabetes mellitus, immunosuppression
Male gender
Pregnancy

5. Clinical Presentation

Type	Features
Uncomplicated	Dysuria, frequency, urgency, suprapubic pain, no systemic signs
Complicated	May have fever, chills, flank pain, systemic toxicity, sepsis, poor response to therapy

6. Investigations

Type	Lab Approach
Uncomplicated	Urinalysis ± urine culture (often empirical treatment)
Complicated	Urine culture mandatory, imaging (USG, CT KUB) if obstruction suspected, blood cultures if febrile

7. Treatment

Type	Approach
Uncomplicated	Short-course oral antibiotics (3–5 days): Nitrofurantoin, TMP-SMX, Fosfomycin, Pivmecillinam
Complicated	Longer course (7–14 days), guided by culture; IV therapy if severe (Ceftriaxone, Piperacillin-tazobactam, Carbapenems for MDR); treat underlying cause (remove catheter, relieve obstruction)

8. Prognosis

Type	Prognosis
Uncomplicated	Excellent, low recurrence with proper hygiene
Complicated	Risk of recurrence, sepsis, renal scarring, abscess

9. Example Cases

Scenario	Type
25-year-old woman with dysuria, no comorbidities	Uncomplicated
60-year-old diabetic man with fever, flank pain	Complicated
Pregnant woman with bacteriuria	Complicated
Patient with indwelling Foley catheter and fever	Complicated

Summary Table

Feature	Uncomplicated	Complicated
Host	Healthy female	Any comorbidity or abnormality
Site	Lower UTI (cystitis)	Any (cystitis, pyelonephritis, sepsis)
Organisms	Usually E. coli	Polymicrobial, resistant organisms
Therapy	Short course	Long course, guided by culture
Prognosis	Excellent	Variable, risk of recurrence

Aphthous Ulcers: Step-by-Step Workup and Management

Leave a reply

1. Clinical Assessment

History

Onset, duration, frequency, and number of ulcers
Pain severity, triggers (trauma, stress, certain foods)
Systemic symptoms: fever, diarrhea, joint pain, fatigue
Family history of similar lesions
Medications (NSAIDs, beta-blockers)
Previous treatments and response

Examination

Location: non-keratinized mucosa (buccal, labial, ventral tongue, floor of mouth)
Size:
- Minor (<1 cm) – most common
- Major (>1 cm, deeper, may scar)
- Herpetiform (multiple small ulcers)
Number: single or multiple
Appearance: round/oval, yellow-white pseudomembrane with erythematous halo
Rule out: secondary causes (herpes simplex, trauma, systemic disease)

2. Investigations (If atypical or recurrent)

Basic labs: CBC, iron studies, vitamin B12, folate (nutritional deficiencies)
CRP/ESR: if systemic symptoms
Serology: celiac disease (tTG-IgA), HIV (if risk factors)
Biopsy: rare, only if persistent >3 weeks, atypical, or suspected malignancy
Microbiology: rarely needed; ulcers are typically non-infectious

3. Classification

Type	Features	Management Focus
Minor	<1 cm, 1–5 lesions, heal 7–14 days	Symptomatic relief
Major	>1 cm, deep, persistent, may scar	Systemic therapy possible
Herpetiform	Multiple, small, coalescing, painful	Combination topical/systemic therapy

4. Management

A. General Measures

Avoid triggers: spicy/acidic foods, trauma
Good oral hygiene
Avoid sodium lauryl sulfate in toothpaste
Stress management
Nutritional supplementation if deficient

B. Topical Therapy (First-line for minor ulcers)

Topical corticosteroids:
- Triamcinolone acetonide 0.1% in orabase
- Fluocinonide 0.05% gel
Topical anesthetics:
- Lidocaine 2% gel for pain relief
Protective agents:
- Orabase, hydroxypropyl cellulose films

C. Systemic Therapy (For severe, recurrent, or major ulcers)

Oral corticosteroids:
- Prednisone short course (e.g., 30–60 mg/day tapering)
Immunomodulators (refractory cases):
- Colchicine, thalidomide, dapsone
Address underlying systemic disease:
- Nutritional deficiencies, IBD, Behçet’s disease, etc.

D. Adjunctive Therapy

Antimicrobial mouth rinses: chlorhexidine gluconate
Pain control: NSAIDs (if not contraindicated)
Laser therapy (experimental for pain reduction and healing)

5. Follow-Up

Minor ulcers: usually self-limiting; review if >3 weeks
Recurrent or major ulcers: monitor frequency, severity, and response to therapy
Evaluate for systemic disease if persistent or atypical

Approach to a Child with Wheeze

Leave a reply

1. Definition

Wheeze is a high-pitched, musical, continuous sound produced by airflow through narrowed airways, typically during expiration.
Indicates airway obstruction at any level (from trachea to small bronchi).

2. Initial Assessment

A. ABC Assessment

Airway: Ensure patency; look for obstruction (secretions, foreign body).
Breathing:
- Respiratory rate, effort (retractions, nasal flaring, grunting)
- Oxygen saturation (SpO₂)
- Presence and distribution of wheeze
- Work of breathing (mild / moderate / severe)
Circulation: Heart rate, capillary refill time, BP, color.

B. Severity Assessment

Severity	Features
Mild	Speaking in sentences, SpO₂ > 94%, mild wheeze
Moderate	Breathless, feeding difficulty, SpO₂ 90–94%
Severe	Cannot talk/feed, SpO₂ < 90%, exhaustion, cyanosis, silent chest

3. Focused History

Aspect	Key Points
Onset & Course	Sudden (foreign body) vs gradual (infection/asthma)
Frequency/Pattern	Recurrent vs first episode
Triggers	Viral infection, allergen, exercise, cold air, smoke
Associated Symptoms	Fever, cough, coryza, vomiting, feeding difficulty
Past Medical History	Previous wheezing, atopy, eczema, prematurity, GERD
Family/Social History	Asthma, allergies, smoking, housing
Drug history	Recent medications, response to bronchodilators

4. Physical Examination

General: Distress, cyanosis, growth, hydration.
Respiratory system:
- Chest expansion, use of accessory muscles
- Percussion (hyperresonant / dull)
- Auscultation:
  - Wheeze: polyphonic (asthma/viral), monophonic (focal obstruction)
  - Air entry: symmetrical or reduced
  - Crackles: suggest infection or bronchiolitis
Cardiac: Murmurs (congenital lesions)
Other systems: Skin (eczema), ENT (allergic rhinitis), clubbing.

5. Differential Diagnosis

Age Group	Common Causes
Infant (<1 yr)	Bronchiolitis, congenital airway anomalies, aspiration, GERD
Toddler (1–5 yr)	Viral-induced wheeze, foreign body aspiration, asthma
Older child (>5 yr)	Asthma, allergic bronchitis, chronic suppurative lung disease

6. Investigations

(Usually guided by clinical picture; many cases diagnosed clinically)

Pulse oximetry – essential.
Chest X-ray – if first episode, focal findings, suspicion of foreign body/pneumonia.
Blood tests – if severe or infection suspected.
Allergy testing / IgE – in recurrent or atopic cases.
Spirometry / Peak Flow – for older cooperative children (asthma diagnosis).
Bronchoscopy – if persistent localized wheeze or suspicion of foreign body.

7. Management

A. Immediate Management

Mild/Moderate:
- Nebulized or inhaled salbutamol (via spacer or nebulizer)
- Oxygen if SpO₂ < 94%
- Oral prednisolone if known asthma or recurrent wheeze
Severe / Life-threatening:
- High-flow oxygen
- Nebulized salbutamol ± ipratropium bromide
- IV steroids (hydrocortisone)
- IV magnesium sulfate / aminophylline / salbutamol if poor response
- Consider PICU referral

B. Underlying Cause

Bronchiolitis – supportive (O₂, fluids, suction)
Foreign body – urgent ENT/pulmonary referral
Asthma – follow stepwise management (as per BTS/SIGN or GINA)

8. Long-term Management

Identify triggers and educate parents on avoidance.
Asthma education: inhaler technique, action plan.
Follow-up to reassess control and adjust therapy.

9. Red Flags

Silent chest, exhaustion, cyanosis
Poor air entry or asymmetry
Persistent localized wheeze
Failure to thrive or recurrent pneumonia
Sudden onset without infection (→ foreign body)

10. Summary Table

Step	Key Action
1	ABC and severity assessment
2	Focused history
3	Physical examination
4	Consider differential diagnoses
5	Targeted investigations
6	Manage acutely + treat cause
7	Educate and follow-up

“The Mysterious Nosebleed Every Month: A Story of Vicarious Menstruation”

Leave a reply

Background

It was a quiet morning at the outpatient clinic when 23-year-old Sita walked in with a puzzled expression. She looked perfectly healthy—until she spoke.

“Doctor,” she began, “every month when my friends get their periods, I don’t bleed like them. Instead, blood comes out from my nose.”

At first, everyone thought it was a coincidence. Maybe sinus problems? Maybe dry air? But the timing was too perfect—every 28 days, her nose would bleed for two or three days, right when her lower abdomen cramped and her mood shifted.

The Curious Case

After a few cycles of this strange pattern, Sita’s physician grew suspicious and ordered tests. Hormones were normal. Sinus scan—clean. Then came the question that changed everything:

“Does your nosebleed coincide with your menstrual cycle?”

When Sita nodded, the puzzle pieces clicked together. The diagnosis: Vicarious Menstruation—a rare and fascinating medical phenomenon where menstrual bleeding occurs from sites outside the uterus.

What Is Vicarious Menstruation?

Vicarious menstruation happens when the body’s endometrial-like tissue or hormone-sensitive mucosa outside the uterus responds to the same hormonal cycle that causes normal menstruation.

In simpler terms, when the uterine lining sheds, some other part of the body “joins in.”

Reported sites include:

Nose (most common – causing cyclical nosebleeds)
Lungs (causing hemoptysis or blood in sputum)
Skin (cyclical bruises or bleeding spots)
Eyes, ears, or even gastrointestinal tract in rare cases

How Does It Happen?

The exact cause isn’t fully understood, but doctors believe it may occur due to:

Hormonal sensitivity: Mucous membranes in certain organs respond to estrogen and progesterone fluctuations.
Endometrial implantation: Rarely, endometrial cells may reach other body sites via blood or lymphatic spread (similar to endometriosis).
Vascular fragility: Hormonal changes may increase capillary fragility during menses.

Sita’s Diagnosis and Treatment

Sita’s case was confirmed after observing the pattern for several months. ENT evaluation found fragile nasal capillaries that responded to hormone fluctuations.

Treatment involved hormonal regulation using oral contraceptive pills to suppress ovulation and stabilize estrogen levels. Within two months, her nosebleeds stopped—and normal menstruation returned.

Why It Matters

Vicarious menstruation reminds us that the human body is deeply interconnected. Hormones don’t just act in one place—they ripple through every organ, tissue, and mood.

For healthcare students and young clinicians, Sita’s story is a gentle warning:

“Always listen to the cycle. Not every period happens through the uterus.”

Takeaway for Readers

If someone experiences cyclical bleeding from any unusual site—nose, eyes, skin—it’s worth noting the timing. Keeping a menstrual diary can help doctors detect such patterns.

It’s rare, yes—but as Sita’s story shows, even the body’s most mysterious messages make sense when we listen carefully.

Table of Contents

1. Normal Anatomy and Physiology

When the Anterior Fontanelle Is Absent at Birth

Causes of Absent Anterior Fontanelle

1. Craniosynostosis (Most Important Cause)

2. Hyperthyroidism (Congenital Thyrotoxicosis)

3. Microcephaly

4. Skeletal Dysplasias

5. Normal Variant

Clinical Evaluation

1. History

2. Physical Examination

Head Examination

Look for Associated Signs

Investigations

1. Imaging

2. Laboratory Tests

Complications

Management

1. Craniosynostosis

2. Neonatal Hyperthyroidism

3. Microcephaly

Clinical Pearls (High-Yield)

Table of Contents

1. Definition

2. Location in Body

3. CK Isoenzymes

Distribution

4. Normal Values

5. Causes of Elevated CK

A. Skeletal Muscle Disorders

B. Rhabdomyolysis

C. Cardiac Causes

D. Neurologic Disorders

E. Other Causes

6. CK in Myocardial Infarction

7. CK in Pediatric Practice

Screening for muscular dystrophy

Evaluation of Hypotonia

Evaluation of Rhabdomyolysis

8. Causes of Decreased CK

9. Drugs Causing Elevated CK

10. Investigation Panel When CK is Elevated

11. CK in Rhabdomyolysis Severity

12. Clinical Pearls (Exam High-Yield)

Table of Contents

1. Definition

2. Typical Patients

3. Etiology

4. Predisposing / Risk Factors

5. Clinical Presentation

6. Investigations

7. Treatment

8. Prognosis

9. Example Cases

Summary Table

Table of Contents

1. Clinical Assessment

2. Investigations (If atypical or recurrent)

3. Classification

4. Management

5. Follow-Up

Table of Contents

1. Definition

2. Initial Assessment

A. ABC Assessment

B. Severity Assessment

3. Focused History

4. Physical Examination

5. Differential Diagnosis

6. Investigations

7. Management

A. Immediate Management

B. Underlying Cause

8. Long-term Management

9. Red Flags

10. Summary Table

Table of Contents

Background

The Curious Case